MarketAbderrahmane Kaidi
Company Profile

Abderrahmane Kaidi

Abderrahmane Kaidi is a biologist whose research focused on cancer and DNA damage. He is best known for committing research fraud that led to his resignation as a lecturer at the University of Bristol. In 2018, he was investigated by the university for alleged misconducts in behaviour and research issues. He was found guilty of faking research, which he admitted as a mean to impress other scientists for collaboration and were not for publication.

Education and career
Kaidi enrolled for Ph.D. in Cellular and Molecular Medicine at the University of Bristol in 2003. Supervised by Christos Paraskeva, he made important contributions to the understanding of how bowel (colorectal) cancer cells grow and die. He received his doctorate in 2007 on the thesis The role of hypoxia in colorectal tumorigenesis. Under postdoctoral programme, he moved to Stephen Jackson's laboratory at the Gurdon Institute of the University of Cambridge, where he focussed his research on DNA damage and remained there for five years. In 2010, he was elected to research fellowship at the Wolfson College of Cambridge. He was also appointed Hershel Smith Research Fellow between 2009 and 2012. The same year, he also received the MRC New Investigator Award. In January 2018, he was appointed among "ambassadors of good practice in science" of eLife. On 13 September 2018, Kaidi resigned from the university after admitting research fraud. == Misconduct ==
Misconduct
In 2018, the University of Bristol received and investigated allegations against Kaidi on two cases, his research work concerned with data fabrication and "behaviour in the laboratory towards other members of his research group." He had prepared fake experiments with made-up data that he gave to a colleague. The university announced that: "Dr Kaidi admitted to having fabricated research data to convince a research collaborator in another institution that certain experiments had taken place, when this was not the case. Dr Kaidi has taken full responsibility for his actions and no other member of his research group is implicated." Following admission of guilt, he resigned from the university. The EMBO paper also in 2010 was written with Sophie E. Polo, Linda Baskcomb, Yaron Galanty and Jackson. It reports the first demonstration of the functions of DNA-binding protein 4 (CHD4) on DNA damage and cell cycle regulation. The Nature paper in 2013, written with Jackson, is about the protein, lysine acetyltransferase, KAT5 that is involved in DNA damage process. During the Bristol investigation, Kaidi confessed that he had made false data in two of his research papers published from Cambridge. Cambridge made its final decision in April 2019 that Kaidi's Science and Nature papers contain falsified data, Nature commented: "The authors cannot confirm the results in the affected figures and thus wish to retract the Article in its entirety. Both authors, Abderrahmane Kaidi and Stephen P. Jackson, agree with the Retraction." The EMBO Journal also investigated its Kaidi's article, but found no "concrete indication" of data manipulation that the editor-in-chief, Bernd Pulverer, declared that further action was not needed. == References ==
tickerdossier.comtickerdossier.substack.com